Canada Life’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Canada Life’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,034	Closed	-$143K	–	2334
2023 Q1	$143K	Buy	34,034 +29,522	+654%	+$153K	﹤0.01%	1922
2022 Q4	$27K	Buy	+4,512	New	+$24.6K	﹤0.01%	2208
2015 Q3	–	Sell	-100	Closed	-$2K	–	2690
2015 Q2	$2K	Hold	100	–	–	﹤0.01%	2629
2015 Q1	$2K	Buy	+100	New	+$2.25K	﹤0.01%	2546

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Canada Life's CTIC Position: Q2 2023 in Review

Canada Life sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 34,034 shares — an estimated $143K sold.

Canada Life first reported a position in CTIC in Q1 2015 and held it in 4 quarters. The position peaked at $143K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Canada Life reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Canada Life sold 34,034 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $143K.
Canada Life first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 4 quarters.
Canada Life's CTI BioPharma Corp. (DE) Common Stock position peaked at $143K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.